Editor's key points † The utility of transversus abdominis plane (TAP) block in Caesarean delivery was assessed by analysing results of previous studies. † TAP block reduced i.v. morphine consumption and pain scores in the first day after surgery. † TAP block can provide effective analgesia after Caesarean delivery when intrathecal morphine has not been used.
Inadequate postoperative pain relief after Caesarean delivery (CD) can negatively impact ambulation, breastfeeding, and even maternal bonding, 1 while effective analgesia improves the amount of breastfeeding and infant weight gain. 2 Neuraxial anaesthesia has become the anaesthetic technique of choice in CD because of its safety and reduction in maternal mortality. 3 The transversus abdominis plane (TAP) block, a field block 4 whose analgesic efficacy in several abdominal surgeries has been confirmed, 5 -7 has also been proposed for postoperative analgesia in parturients undergoing elective CD under spinal anaesthesia. 8 However, the analgesic utility of TAP block remains controversial; some trials comparing it with placebo reported significant advantages, 8 9 while others found no analgesic benefit. 10 11 Reviews examining the analgesic effects of TAP block in various surgeries have not provided definitive answers regarding the specific role of TAP block in CD. A Cochrane review examining the efficacy of TAP block in abdominal surgeries excluded CD. 12 A recent meta-analysis supporting TAP block for its effective pain relief included only one trial in the setting of CD. 13 A 2012 qualitative systematic review 14 examined the role of TAP block across all abdominal surgeries and raised questions about its role in the setting of multimodal analgesia but stopped short of conducting any further analysis specific to CD. The purpose of this systematic review was to determine whether or not TAP block is effective in providing pain relief after CD. The primary outcome was morphine consumption in the first 24 h, an important issue for the breastfeeding woman.
Eligibility criteria
We searched the literature for randomized controlled trials (RCTs) that compared TAP block with placebo in patients undergoing elective CD under spinal anaesthesia. We included trials that used both ultrasound and landmark guidance for the single-shot TAP block technique. In addition, we searched the bibliographies of relevant reviews and identified RCTs that fulfilled the inclusion criteria. We also searched for and reviewed published abstracts of anaesthesiology meetings that were held during the period 2007 -2012 by the American Society of Anesthesiologists, the American Society of Regional Anesthesia, the Society of Obstetric Anesthesia and Perinatology, the European Society of Anaesthesiology, and the European Society of Regional Anaesthesia. Finally, we sought unpublished data at 'clinicaltrials.gov' as a measure of publication bias. No language restriction was used. The final list of qualifying studies was derived by consensus among the three authors. Excluded trials are listed in the Appendix.
Literature search

Data collection and presentation
Quality of the reviewed trials was assessed independently by two of the authors (F.W.A. and C.B.M.) using the Cochrane Risk of Bias tool. 16 A final score was assigned for each trial by consensus. I.V. morphine consumption during the first 24 h after CD was defined as a primary outcome. Rest and dynamic pain visual analogue scale (VAS) scores (10 cm unmarked line in which 0 cm, no pain, and 10 cm, worst pain imaginable) at 24 h and maternal opioid-related sideeffects (sedation, pruritus, nausea, and vomiting), patient satisfaction, and block-related complications were designated as secondary outcomes. A standardized data collection form was used for outcome data extraction. Data were recorded independently by two of the authors (F.W.A., C.B.M.) to avoid transcription errors; discrepancies were resolved by re-inspection of the original data.
Meta-analysis
The data were then entered into the statistical program (by C.B.M.) and rechecked (by F.W.A.). When possible, meta-analytic techniques (Revman 5.1, Cochrane Library, Oxford, UK) were used to combine the data. Random effect modelling was used in analysing continuous and dichotomous outcomes. The standardized mean difference and 95% confidence interval (CI) were calculated for continuous outcomes; while odds ratio (OR) and 95% CI were calculated for dichotomous outcomes. Differences were considered statistically significant when the 95% CI did not include 0. The I 2 statistic was used to assess heterogeneity. 17 As the analgesic efficacy of spinal morphine in postoperative pain control is well recognized, 18 -20 we hypothesized-a priori-that it constitutes a co-intervention that would generate significant heterogeneity among the pooled trial results. We therefore performed subgroup analysis according to administration of intrathecal morphine (ITM), where (SM2) referred to the group of RCTs where spinal morphine was not used, while (SM+) referred to the group of RCTs where spinal morphine was used.
Results
Search results, including retrieved, excluded, and reviewed RCTs, are summarized by a flowchart in Figure 1 . We found five trials 5 8-11 with a total of 312 patients that met the inclusion criteria. The trials reviewed included one 11 where TAP block and placebo were compared in the presence and absence of spinal morphine, resulting in two distinct comparisons. Table 1 summarizes trial characteristics and the outcomes sought in each of the reviewed trials. The methodological quality of the included studies and the risk of bias are described in Table 2 ; Table 3 defines the analgesic regimens used in the reviewed trials. In addition to the published studies, we found five unpublished studies at 'clinicaltrials.gov' comprising 438 patients who potentially meet the inclusion criteria but were still in the recruitment phase.
Postoperative morphine consumption
Postoperative i.v. morphine consumption during the first 24 h in each study and pooled consumption are shown in Figure 2 . When spinal morphine is excluded from the multimodal analgesic regimen (SM2), we found that TAP block, compared with placebo, reduced the mean 24 h i.v. morphine consumption by 24 mg (95% CI 239.65 to 27.78). This statistically significant reduction (P¼0.004) favours TAP block. When both groups received spinal morphine (SM+), TAP block did not significantly reduce morphine consumption (mean difference 2 mg, 95% CI 23.47 to 7.46, P¼0.47). The pooled morphine consumption of the SM+ and SM2 subgroups was lower by 15 mg (95% CI 233.10 to 2.56) in patients receiving TAP block, although this lacked statistical significance (P¼0.09). Heterogeneity among the studies in the SM2 subgroup and in the pooled studies was significant (I 2 ¼0.94 and 0.97, respectively, P,0.00001).
Rest pain scores
The 24 h rest VAS scores for individual and pooled studies are shown in Figure 3 . Compared with placebo in the (SM2) setting, TAP block reduced 24 h rest VAS scores by 0. Dynamic pain scores Figure 4 shows the 24 h dynamic VAS scores for individual and pooled studies. Difference between the groups were not statistically significant for either the SM2 or the SM+ studies.
Opioid-related side-effects
The reviewed trials were inconsistent in reporting opioid-related side-effects. Four trials reported the incidence of postoperative nausea and vomiting (PONV); 5 8 9 11 while three reported the incidence of sedation, 5 8 11 and another two reported the incidence of pruritus. 5 11 The inconsistency in reporting these outcomes and the heterogeneity of assessment when these outcomes were reported precludes quantitative analysis. Qualitative analysis of trials in the (SM2) subgroup showed that all of the trials 5 8 9 11 that assessed the incidence of PONV reported reduced incidence in patients who received TAP block. Furthermore, one 8 of the three 5 8 11 trials that assessed sedation showed reduced incidence with TAP block, while two 5 11 showed no difference. As for pruritus, one trial 5 showed no difference, while another 11 showed reduced incidence with TAP block.
Opioid-related side-effects assessment in the (SM+) group was performed in only one trial; the incidence of pruritus favoured TAP block, while the incidence of PONV favoured control group. 11 Neonatal opioid-related sideeffects of TAP block such as somnolence and difficulty with breastfeeding were not studied in any of the trials. There was no reported difference in the incidence of chronic pain in the single trial that assessed this outcome. 10 TAP block resulted in improved patient satisfaction in two trials 5 9 and reduced satisfaction in one.
11
Three of the trials 5 9 10 reviewed examined block-related complications, but none was reported.
Discussion
This review suggests that TAP block constitutes an effective analgesic option capable of reducing 24 h opioid consumption, 24 h rest pain scores, and PONV in parturients undergoing CD who receive a multimodal analgesic regimen that excludes ITM. While the improvement in pain scores was modest and not clinically relevant, the difference in i.v. morphine consumption was robust and clinically significant. These differences are not significant in the presence of ITM. It should be noted that heterogeneity in baseline morphine consumption among the studies might have significantly contributed to the difference between the (SM+) and (SM2) groups. There were insufficient data to conclude that TAP affects the incidence of other opioid-related side-effects such as sedation or pruritus. Reduction in opioid analgesics is generally desirable in CD and more so when spinal morphine is not used. Although opioid analgesics can be taken safely by lactating women, some opioids can result in significant exposures and toxicity in infants, 21 including the risk of neurobehavioural depression in the breastfed newborn. 22 Future research is needed to examine the ability of TAP block to reduce opioid metabolites in infant plasma. As a component of spinal anaesthesia, the superiority of post-Caesarean analgesia produced by long-acting spinal opioids over their systemic counterparts 18 19 makes them an integral part of multimodal analgesic regimens. 20 23 24 Since neuraxial anaesthesia has been established as the best modality for CD, it has become difficult to justify excluding a small dose of ITM, 25 given the superior analgesia it produces, the prolonged duration of this analgesia, 26 -28 and its ability to treat both somatic 20 and visceral 29 -31 components of pain. The absence of definitive analgesic advantages of TAP block when added to multimodal analgesic regimens inclusive of ITM, 10 11 and its inferiority, as a substitute to ITM demonstrated in three recent trials, 11 32 33 suggest a potential role of TAP block as part of the post-Caesarean multimodal analgesic regimen in practice settings that do not use long-acting intrathecal opioids or when their use is either not feasible or contraindicated. There is also recent evidence to suggest that TAP block might be beneficial for patients undergoing CD under general anaesthesia. 34 35 Although not studied, TAP block might be useful when other components of multimodal analgesia such as non-steroidal anti-inflammatory drugs (NSAIDs) are contraindicated. Patients with conditions such as hypersensitivity to NSAIDs, renal impairment, concomitant use of nephrotoxic drugs, or a history of peptic ulcer disease might benefit from TAP block as a practical alternative for pain relief.
This review is limited by the small size of included studies and the significant heterogeneity in reporting the primary and secondary outcomes. Our sample comprised 312 patients; however, there are five unpublished trials with 438 patients reported at 'clinicaltrials.gov' for which we have no data. This represents a significant risk of publication bias (Appendix). Also, some important outcomes were missing in all trials reviewed, such as differentiation between visceral and somatic pain, effect of TAP block on breastfeeding, and its effect on the incidence of chronic pain after CD. Further limitations include differences in TAP block technique and doses of local anaesthetics used. In the absence of dose-ranging studies that assess the impact of various volumes and concentrations of local anaesthetics on post-Caesarean analgesia produced by TAP block, and since the studies reviewed did not assess patients for the presence of sensory block, we cannot ascertain the success of TAP blocks performed. Additionally, our choice to combine ultrasound-guided and landmark-guided TAP blocks might be challenged by recent evidence that indicates differences between the two techniques. Anatomically guided TAP blocks performed in the triangle of Petit can produce prolonged analgesia, and theoretically less morphine consumption, compared with their ultrasound-guided counterparts, 14 an observation that can be attributed to paravertebral spread. 36 There is evidence to suggest that only a small fraction of landmark-guided blocks deposit local anaesthetics in the correct anatomical plane, 37 thus rendering their analgesic efficacy questionable.
Finally, the authors wish to underscore the ethical concern In summary, TAP block constitutes an effective analgesic option for postoperative analgesia after CD performed under spinal anaesthesia when spinal morphine is not used. There is currently no evidence that the TAP block is of benefit when ITM has been administered.
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